Investor FAQs

Show All
Where is Verve Therapeutics’ corporate headquarters?
Verve is headquartered at 500 Technology Square, Suite 901 Cambridge, MA, 02139.
When was the company founded?
Verve was founded and commenced operations in 2018.
When did Verve go public?
Verve’s initial public offering (IPO) occurred on June 16, 2021.
When is Verve’s fiscal year-end?
Verve’s fiscal year ends on December 31st.
How is Verve’s stock traded?
Verve is traded on the Nasdaq Global Market under the ticker symbol VERV, and its CUSIP number is 92539P 101.
Who is Verve’s transfer agent?
Computershare Trust Company, N.A.
P.O. Box 505000
Louisville, KY 40233
www.computershare.com
Toll: +1 781 575-3100
Toll Free: 800-736-3001
Who are Verve’s independent auditors?
Ernst & Young LLP
200 Clarendon St, Boston, MA 02116
Who is Verve’s legal counsel?
Wilmer Cutler Pickering Hale and Dorr LLP
60 State Street
Boston, MA 02109
Where can I get the latest corporate news releases and financial reports?
Verve’s press release archives can be viewed here.
How can I view documents Verve has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Verve’s SEC filings can be viewed here
Whom should I contact if I have further questions?
You can submit queries to Verve’s investor relations department by contacting ir@vervetx.com